Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Mary C. Ritter"'
Publikováno v:
Diabetes. 46:414-420
Although the relationship between the actions of cholesteryl ester transfer protein (CETP) and atherosclerosis is complex, a strong body of evidence suggests that its activity (cholesteryl ester transfer [CET]) is proatherogenic. We have previously s
Autor:
Helen Lambeth, Abbas E. Kitabchi, Emer Huss, Mary C. Ritter, Osama Gaber, Richard Thistlethwaite, John D. Bagdade
Publikováno v:
Diabetes Care. 19:1108-1112
OBJECTIVE Cholesteryl ester transfer (CET) is accelerated in patients with IDDM treated with conventional (subcutaneous) insulin therapy (CIT) and a number of other disorders associated with premature cardiovascular disease. We have shown that in IDD
Autor:
Mary C. Ritter, John D. Bagdade
Publikováno v:
Lipids. 31:1-7
While it is known that the transfer of cholesteryl ester (CE) from high density lipoprotein (HDL) to the apo B-containing lipoproteins is increased in patients with diabetes, the extent to which the various lipoprotein fractions engage in neutral lip
Publikováno v:
Arteriosclerosis and Thrombosis: A Journal of Vascular Biology. 14:1933-1939
Patients with insulin-dependent diabetes mellitus (IDDM) have proatherogenic disturbances in cholesteryl ester transfer (CET) despite intensive subcutaneous insulin therapy (ISC). Since CET is activated by insulin-sensitive lipoprotein lipase (LPL),
Autor:
Mary C. Ritter, J. D. Bagdade
Publikováno v:
European Journal of Clinical Investigation. 24:607-614
In an earlier study we demonstrated that the transfer of cholesteryl ester (CET) estimated as the net mass of CE lost from HDL to the apoB-containing lipoproteins (VLDL + LDL) during incubation of plasma is accelerated in normolipidaemic patients wit
Publikováno v:
Arteriosclerosis and Thrombosis: A Journal of Vascular Biology. 12:1146-1152
While the effects of omega-3 (n-3) fatty acids present in marine lipids on plasma lipoprotein levels have been intensively studied, less is known about their impact on reverse cholesterol transport. For this reason, for a 3-month period we studied th
Publikováno v:
European Journal of Clinical Investigation. 21:161-167
Abnormalities in cholesteryl ester transfer (CET) may play a role in the development of diabetic arterial vascular complications. To assess this important step systematically in reverse cholesterol transport, we have studied 20 treated, clinically st
Publikováno v:
Atherosclerosis. 84:145-154
Despite probucol's capacity to induce regression of tendinous xanthomata and reduce whole plasma and LDL cholesterol (LDL-C) in patients with hypercholesterolemia, its therapeutic use in the United States has been limited because of concern about its
Publikováno v:
Journal of Lipid Research, Vol 31, Iss 7, Pp 1263-1269 (1990)
Optimally effective lipid-lowering agents should not only restore plasma lipids to normal levels but also correct potentially atherogenic alterations in lipoprotein composition and function often present in hyperlipidemic patients. Lovastatin, a comp
Publikováno v:
Diabetologia. 39(4)
Patients with insulin-dependent diabetes mellitus (IDDM) have a pathological increase in cholesteryl ester transfer (CET) that enriches the apolipoprotein B-containing lipoproteins with cholesteryl ester and increases their atherogenicity. Since we h